Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nutrison Bolus Energy HP liquid
0914011T0BBAAAA
|
Nutrison tube feed 1.6kcal/ml higher protein | Tube feed 1.6kcal/ml higher protein (0914011) | Nutrition and Blood | No data available |
|
Nutrison MCT liquid
0914072A0BBAAAA
|
Nutrison tube feed 1 kcal/ml MCT based | Tube feed 1 kcal/ml MCT based (0914072) | Nutrition and Blood | No data available |
|
Nutrison PlantBased 2kcal HP liquid
0914011S0BBAAAA
|
Nutrison tube feed 2kcal/ml, higher protein, plant based | Tube feed 2kcal/ml, higher protein, plant based (0914011) | Nutrition and Blood | No data available |
|
Nutrison PlantBased 2kcal HP Multi Fibre liquid
0914011R0BBAAAA
|
Nutrison tube feed 2kcal/ml w fibre higher prot plant based | Tube feed 2kcal/ml w fibre higher prot plant based (0914011) | Nutrition and Blood | No data available |
|
Nutrizym 10 gastro-resistant capsules
0109040N0BEADAT
|
Nutrizym | Pancreatin | Gastro-Intestinal System | No data available |
|
Nutrizym GR modified-release capsules
0109040N0BEABAK
|
Nutrizym | Pancreatin | Gastro-Intestinal System | No data available |
|
Nuvaxovid JN.1 COVID-19 Vaccine 0.5ml dispersion inj vials
1404000ATBEACBY
|
COVID-19 Novavax | Coronavirus vaccine | Immunological Products and Vaccines | No data available |
|
Nuvaxovid JN.1 COVID-19 Vaccine 0.5ml dose inj pfs
1404000ATBEADCD
|
COVID-19 Novavax | Coronavirus vaccine | Immunological Products and Vaccines | No data available |
|
Nuvaxovid XBB.1.5 COVID-19 Vaccine 0.5ml inj multidose vials
1404000ATBEABBP
|
COVID-19 Novavax | Coronavirus vaccine | Immunological Products and Vaccines | No data available |
|
Nuvelle Continuous tablets
0604011L0BEACAK
|
Nuvelle | Estradiol with progestogen | Endocrine System | No data available |
|
Nuvelle tablets
0604011L0BEAAAF
|
Nuvelle | Estradiol with progestogen | Endocrine System | No data available |
|
Nuvelle TS patches
0604011L0BEABAZ
|
Nuvelle | Estradiol with progestogen | Endocrine System | No data available |
|
Nycopren 250mg gastro-resistant tablets
1001010P0BGAAAH
|
Nycopren | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Nycopren 500mg gastro-resistant tablets
1001010P0BGABAI
|
Nycopren | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Nylon elastic colostomy belt
23305303012
|
Nylon elastic colostomy belt | Belts | Stoma Appliances | No data available |
|
Nyogel 0.1% eye gel
1106000Z0BGAAAR
|
Nyogel | Timolol | Eye | No data available |
|
Nystamont 100,000units/ml oral suspension
0502030B0BGAAAX
|
Nystamont | Nystatin | Infections | No data available |
|
Nystan 100,000unit pastilles
1203020N0BBAAAA
|
Nystan (Mouthwash) | Nystatin | Ear, Nose and Oropharynx | No data available |
|
Nystan 100,000unit pessaries
0702020T0BCACAF
|
Nystan (Vaginal) | Nystatin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Nystan 100,000units/4g application vaginal cream
0702020T0BCABAE
|
Nystan (Vaginal) | Nystatin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Nystan 100,000units/g ointment
1310020U0BDACAD
|
Nystan (Topical) | Nystatin | Skin | No data available |
|
Nystan 500,000unit tablets
0502030B0BBAAAI
|
Nystan (Systemic) | Nystatin | Infections | No data available |
|
Nystatin 100,000unit pastilles
1203020N0AAAAAA
|
Nystatin (Mouthwash) | Nystatin | Ear, Nose and Oropharynx | No data available |
|
Nystatin 100,000units/4g application vaginal cream
0702020T0AAAEAE
|
Nystatin (Vaginal) | Nystatin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Nystatin 100,000units/g / Tolnaftate 1% cream
1310020U0AAAGAG
|
Nystatin (Topical) | Nystatin | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.